Nicole Romeo
Medical · la Jolla, CANPI 1861435323
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,252 of the $18,022 with a category attached, or 68.0%. 26 manufacturers reported payments, led by Medtronic at 38.2% of the total. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 523 payments — averaging $34.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abbott$6K
- Actelion Pharmaceuticals US, Inc.$1K
- Abiomed$621
- Merck$447
- Novartis$445
- plus $2K from 20 others
What the payments were for
- Speaking & faculty fees$2,71315%
- Travel & lodging$3,05717%
- Food & beverage$12,25268%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 46 | $6,879 |
| Abbott | 136 | $5,901 |
| Actelion Pharmaceuticals US, Inc. | 162 | $1,434 |
| Abiomed | 10 | $621 |
| Merck | 19 | $447 |
| Novartis | 31 | $445 |
| Cvrx, Inc. | 21 | $294 |
| United Therapeutics Corporation | 12 | $239 |
| Scpharmaceuticals Inc. | 11 | $227 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $220 |
| Bayer | 14 | $217 |
| Novo Nordisk | 9 | $187 |
| Kestra Medical Technology Services, Inc. | 6 | $171 |
| E.r. Squibb & Sons, L.L.C. | 7 | $122 |
| Boehringer Ingelheim | 5 | $121 |
| Alnylam Pharmaceuticals Inc. | 4 | $103 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $93 |
| Pfizer | 3 | $63 |
| AstraZeneca | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $39 |
| Johnson & Johnson | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Bridgebio Pharma, Inc. | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,621
- LINQ II$671
- Impella$374
- MitraClip$312
- CARDIOMEMS$118
- Barostim Neo System$117
How this compares
$18,022 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sandostatin Lar DepotOctreotide Acetate,mi-Spheres | 27 | $120,657 |
| Everolimus | 14 | $21,312 |
| EntrestoSacubitril/Valsartan | 14 | $12,475 |
| Tacrolimus | 30 | $6,876 |
| VascepaIcosapent Ethyl | 11 | $3,360 |
| Losartan Potassium | 45 | $736 |
| Rosuvastatin Calcium | 38 | $647 |
| Mycophenolate Mofetil | 11 | $586 |
| Bumetanide | 19 | $548 |
| Hydralazine Hcl | 33 | $315 |
| Pantoprazole Sodium | 30 | $303 |
| Amiodarone Hcl | 30 | $299 |
| Escitalopram Oxalate | 14 | $277 |
| Metoprolol Succinate | 14 | $250 |
| Mirtazapine | 15 | $242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisSandostatin Lar Depot, Entresto | $445 | $133,13341 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in la Jolla
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.